Glutathione may cause digestive symptoms, like nausea and vomiting
[Google Scholar] Bijalwan S, Randhawa GK, Kaur T: A prospective, randomized and open label study to compare efficacy, safety and quality of life impact of topical glutathione (2%) in comparison to topical tranexamic acid (3%) in adult melasma patients
Previous studies reported on the role of ATP in cellular antioxidant synthesis and elimination of ROS 11,16
12 Summary This review summarizes current knowledge on the effects of KD on the skin, particularly its potential therapeutic role in inflammatory skin diseases, such as acne vulgaris, psoriasis, hidradenitis suppurativa, and skin cancer
Retatrutide is not on FDA's bulk drug substances list approved for 503A compounding as of May 2026